testosterone undecanoate

Abstract Background Adding testosterone to hormonal therapy could improve sexual function and general well-being among women during climacteric. We evaluated the effectiveness of testosterone undecanoate on sexual function in postmenopausal women utilizing the standardized questionnaire FSFI...

My doctor has put in an order for a blood dump, should I go or lower the dose slightly. September blood tests RED BLOOD CELL COUNT 5.66 Reference Range: 4.20-5.80 Million/uL HEMOGLOBIN 16.8 Reference Range: 13.2-17.1 g/dL HEMATOCRIT 50.4 H Reference Range: 38.5-50.0 PLATELET COUNT 281 Reference...

Another oral testosterone undecanoate. https://www.empr.com/home/news/fda-approves-oral-testosterone-replacement-therapy-kyzatrex/

I recently did a blood test which included total T, I was surprised that my total T was 868 ng/dl. This was 12 weeks after injecting testosterone undecanoate. Typically I would have expected around 600 ng/dl. A few days later, I discovered I was seriously dehydrated. So I wondered, was...

The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism. These men have low testosterone levels due to specific medical conditions, such as genetic disorders like Klinefelter syndrome or...

As of September 17, 2014 (last FDA meeting to review requirements for testosterone studies and products), approval of testosterone replacement products has become a lot more difficult in the United States. This was fueled by two flawed studies that linked testosterone to cardiovascular risks and...

This product is already approved in Canada and other countries. It is a safe oral testosterone undecanoate but it has a short life, so it has to be taken 3 times a day. I am not sure who would be willing to take a pill that frequently when we now have some many options that can be taken once a...

Update on Aveed (Nebido- testosterone undecanoate- long acting testosterone): After a few problems with the FDA review process that have slowed down its approval by 3 years, this was the last announcement: "Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP)...